Platelets in chronic liver disease, from bench to bedside

被引:52
|
作者
Ramadori, Pierluigi [1 ]
Klag, Thomas [2 ]
Malek, Nisar Peter [2 ]
Heikenwalder, Mathias [1 ]
机构
[1] German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[2] Univ Tubingen, Dept Internal Med 1, Muller Str 10, D-72076 Tubingen, Germany
关键词
Platelets; cirrhosis; HCC; cancer; immune system; immunology; NASH; NAFLD; LOW-DOSE ASPIRIN; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL; HCV INFECTION; KUPFFER CELLS; DRUG-THERAPY; MOUSE MODEL; LIFE-SPAN;
D O I
10.1016/j.jhepr.2019.10.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the last decade, numerous studies revealed physiologic and pathophysiologic roles of platelets beyond haemostasis, a process to prevent and stop bleeding. These include the activation of the immune system and the promotion of inflammation, infection and cancer. Hence, the emerging view on the role of platelets has shifted - platelets are nowseen as alert "sentinels" of the immune compartment, rather than passive bystanders. Herein, we review well-established and newly discovered features of platelets that define their natural role in maintaining blood haemostasis, but also their functional relationship with other cells of the immune system. We focus on recent studies underlining functional involvement of platelets in chronic liver diseases and cancer, as well as the effects of anti-platelet therapy in these contexts. Finally, we illustrate the potential of platelets as possible diagnostic and therapeutic tools in liver disease based on recently developed methodologies. (c) 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:448 / 459
页数:12
相关论文
共 50 条
  • [41] ROLE OF PDE4 ENZYMES IN ALCOHOLIC LIVER DISEASE: FROM BENCH TO BEDSIDE
    Gobejishvili, Leila
    Wahlang, Banrida
    Rodriguez-Alvarez, Walter
    Wang, Yali
    Barve, Shirish
    McClain, Craig J.
    GASTROENTEROLOGY, 2018, 154 (06) : S1118 - S1118
  • [42] Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
    Gariani, K.
    Philippe, J.
    Jornayvaz, F. R.
    DIABETES & METABOLISM, 2013, 39 (01) : 16 - 26
  • [43] Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench
    Rodriguez, Walter E.
    Wahlang, Banrida
    Wang, Yali
    Zhang, Jingwen
    Vadhanam, Manicka V.
    Joshi-Barve, Swati
    Bauer, Philip
    Cannon, Robert
    Ahmadi, Ali Reza
    Sun, Zhaoli
    Cameron, Andrew
    Barve, Shirish
    Maldonado, Claudio
    McClain, Craig
    Gobejishvili, Leila
    HEPATOLOGY, 2019, 70 (06) : 1958 - 1971
  • [44] Chronic Inflammatory Demyelinating Polyradiculoneuropathy: From Bench to Bedside
    Peltier, Amanda C.
    Donofrio, Peter D.
    SEMINARS IN NEUROLOGY, 2012, 32 (03) : 187 - 195
  • [45] Editorial: From bench to bedside: the challenge of chronic pain
    Maiaru, Maria
    Hollywood, Amelia
    Trimboli, Michele
    FRONTIERS IN PAIN RESEARCH, 2023, 4
  • [46] Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside
    Smyk, Daniel S.
    Bogdanos, Dimitrios P.
    Kriese, Stephen
    Billinis, Charalambos
    Burroughs, Andrew K.
    Rigopoulou, Eirini I.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (02) : 110 - 121
  • [47] From bench to bedside: Chronic inflammation and cardiovascular risks
    Lopez-Candales, Angel
    Harris, David
    IJC METABOLIC & ENDOCRINE, 2016, 12 : 1 - 2
  • [48] Krabbe Disease: One Hundred Years From the Bedside to the Bench to the Bedside
    Wenger, David A.
    Rafi, Mohammad A.
    Luzi, Paola
    JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (11) : 982 - 989
  • [49] Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside
    Olivieri, Jacopo
    Coluzzi, Sabrina
    Attolico, Imma
    Olivieri, Attilio
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 1908 - 1931
  • [50] ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside
    Wen, Lu
    Wei, Qingqing
    KIDNEY360, 2022, 3 (07): : 1128 - 1131